Large-scale gene expression studies of breast cancer cell lines and primary tumor tissue were instrumental in identifying the selective upregulation of FOXA1 in luminal breast cancers and its strong correlation with ESR1 expression [7,8,34,35,36]. This evidence concerns the gene FOXA1 and breast carcinoma.